Clinical trials
Relatives clinical trials
Below are recruiting relatives clinical trials, each written for real people, not researchers. We’re tracking 2,011 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06905587RecruitingPhase 3
Methylphenidate for fatigue in young brain tumor survivors
This trial tests whether the medicine methylphenidate (often used for ADHD) can help reduce severe fatigue in children and teens who have finished treatment for a brain tumor. If you're a young brain tumor survivor struggling with ongoing tiredness, this study may offer a new option.
AalborgAges 6–27 - NCT06906406Recruiting
Quality of life in children with clubfoot
This study looks at how clubfoot affects the daily life and well-being of children aged 2 to 15. It uses questionnaires to understand their physical and emotional health, which can help improve care and support for kids with this condition.
Drammen, BuskerudAges 2–15 - NCT06916754Recruiting
Comparing two therapies for alcohol addiction
This study compares two types of therapy to help people reduce or stop drinking. You will attend weekly sessions for 12 weeks and learn new skills or use hypnotherapy to support your recovery.
IstanbulAges 18–65 - NCT06924008Recruiting
Eye contact therapy for adults with autism
This study tests a new program to help adults with autism feel more comfortable using eye contact. It is for people who are already getting treatment at a specialized autism center in the Netherlands.
Deventer, OverijsselAges 18–65 - NCT06924021Recruiting
AMD Eye Image Library (ABID) Study
This study is creating a library of eye images to help doctors better diagnose age-related macular degeneration (AMD). You can join if you have healthy eyes or any stage of AMD that has never been treated.
Fargo, North DakotaAges 50 years+ - NCT07021859Recruiting
Migraine with aura study using CGRP to trigger attacks
This study tests whether a substance called CGRP (a protein linked to migraines) can safely trigger a migraine with aura in people who already have this condition. You'll receive an infusion and be monitored to see how your body responds.
Glostrup MunicipalityAges 18–65 - NCT07024628Recruiting
Heat safety messages from your doctor
This study tests whether health tips sent by text or email from your family doctor can help you stay safe during heat waves. If you live in Eastern Ontario and have a regular primary care provider, you may be able to join and get these messages.
Ottawa, OntarioAges 18 years+ - NCT07048561Recruiting
Fitness and thinking skills in older adults
This study looks at how physical fitness connects to thinking skills like planning and memory in older adults. If you join, you will complete fitness tests and thinking tasks to help researchers understand this link.
TaipeiAges 65 years+ - NCT07050381Recruiting
Risk factors for ruptured aneurysms in brain AVM
This study looks at why certain aneurysms tied to a brain AVM tear more often. If you have a brain AVM with aneurysms that bled, your data may help doctors understand how to prevent future ruptures.
Nanjing, JiangsuAges Any age - NCT07060547Recruiting
Blood test for alcohol-related liver disease
This study tests a new blood test (HepQuant DuO) to see how well it measures liver function in people with alcohol-related liver disease. If you have liver damage from alcohol and either a recent serious liver flare-up or also a fatty liver condition (NASH), this study may help your doctors understand your liver better.
Redwood City, CaliforniaAges 18 years+ - NCT07061938RecruitingPhase 1/Phase 2
Study of ACE1831 for active IgG4-related disease
This trial tests a new drug called ACE1831 for people with active IgG4-related disease that affects more than one organ. It aims to see if the drug can safely control the disease and reduce the need for steroids.
Atlanta, GeorgiaAges 18–75 - NCT07064759RecruitingPhase 3
Gene therapy injection for wet age-related macular degeneration
This trial tests a one-time gene therapy injection (4D-150) for wet AMD. It might help reduce the need for frequent anti-VEGF eye injections by targeting the underlying cause of new blood vessel growth.
Scottsdale, ArizonaAges 50 years+ - NCT07068165RecruitingPhase 2/Phase 3
Lenalidomide for active IgG4-related disease
This study tests a drug called lenalidomide to see if it can help control active IgG4-related disease, a condition that causes inflammation and swelling in organs. The drug is taken by mouth, and the study compares it to a placebo (a pill with no medicine).
BeijingAges 18–75 - NCT07080476Recruiting
Kinesio taping for chronic swelling after breast cancer
This trial tests whether Kinesio taping, a special type of elastic tape, can reduce long-term swelling in the breast or upper body (trunk) after breast cancer treatment. If you have had breast cancer and still have swelling lasting more than six months, this study may help find a new way to manage that swelling.
AntwerpAges 18 years+ - NCT07084883Recruiting
AI system for early AMD detection
This trial tests an AI system designed to catch early signs of late age-related macular degeneration (AMD) before it's diagnosed. It's for people who haven't yet been diagnosed with AMD or treated for retinal disease.
Richmond Hill, New YorkAges 50 years+ - NCT07087145Recruiting
HPV test by mail for men with HIV
This trial explores if mailing an HPV self-test kit to your home is a good way to screen for HPV. It's for men over 35 who have sex with men, including trans women, and are living with HIV.
San Francisco, CaliforniaAges 35 years+ - NCT07134387Recruiting
Long-term effects of BPD on family quality of life
This study looks at how bronchopulmonary dysplasia (BPD), a lung condition in premature babies, affects the long-term health and quality of life of children and their families. Parents or caregivers of children born early with or without BPD can join to compare experiences.
München, BavariaAges birth–18 years - NCT07148791RecruitingPhase 2
CAR-T therapy for relapsed or refractory IgG4-related disease
This trial tests whether a special type of immune cell therapy (CAR-T) can help people whose IgG4-related disease persists despite steroids or rituximab. It focuses on those with inflammation in two or more major organs.
Beijing, Beijing MunicipalityAges 18–75 - NCT07241325Recruiting
Emotional health and quality of life in type 2 diabetes
This study looks at how adults with type 2 diabetes feel emotionally and mentally, and how their health affects their daily life. Participants will fill out questionnaires about their mood, well-being, and quality of life.
TaipeiAges 18 years+ - NCT07249216Recruiting
Eye fluid study for wet AMD treatment response
This study looks at eye fluid from people with untreated wet AMD to find out why some don't respond well to standard injections. The goal is to improve future treatments.
SingaporeAges 50 years+ - NCT07264439Recruiting
Virtual reality with hypnosis for Alzheimer's patients during hygiene care
This trial tests whether virtual reality headsets showing hypnosis scenes can reduce agitation and resistance during bathing or toileting in people with Alzheimer's disease. It aims to make daily care calmer and less stressful for patients and caregivers.
AmiensAges 18 years+ - NCT07283315RecruitingEarly Phase 1
NK cell therapy for children with autoimmune diseases
This trial tests a new treatment using special NK cells (a type of immune cell) designed to target and calm overactive B cells that cause autoimmune diseases like lupus and kidney inflammation. It may help children whose current treatments aren't working well enough.
Hangzhou, ZhejiangAges 3 years+ - NCT07321158Recruiting
Electrical stimulation for arm spasticity after first injury
This trial tests whether different pulse durations of electrical stimulation (NMES) can reduce muscle tightness (spasticity) in the arm after a first-time brain or spinal cord injury. It uses special brain-wave tests to measure changes.
Athens, AtticaAges 18 years+ - NCT07330674RecruitingPhase 1
Safety study of ABF-101 in healthy people and AMD patients
This trial tests the safety of a new drug called ABF-101 in two groups: healthy volunteers (Part A and B) and people with age-related macular degeneration (AMD, Part C). If you join, you will help researchers understand how the drug affects the body and if it's safe enough to study further.
Dallas, TexasAges 18–50
Hear when a new Relatives trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for relatives?
- Yes. Clin2 currently lists 2,011 recruiting relatives studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a relatives trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a relatives trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.